Slow, pinched injections reduce it
In Study 3, at Week 68, the body weight was missing for 4% and 6.7% of patients randomized to WEGOVY injection and placebo, respectively
63% did not request patient-reported clinical measures such as blood pressure, blood glucose, or cholesterol
Clinical evidence shows that discontinuing GLP-1 therapy typically results in weight regain, with patients regaining approximately two-thirds of lost weightincluding abdominal fatwithin one year of stopping
Our team will create a personalized plan to ensure youre on the right track from day one
For people who struggled with nausea on tirzepatide, retatrutide offers a slower alternative protocol (2 mg increments over 20 weeks, detailed in our retatrutide dosage guide)